STAA Q4 2024 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$49M-35.8% YoY

Gross Profit

$32M64.7% margin

Operating Income

-$28M-57.0% margin

Net Income

-$34M-69.9% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

-44.7%

Cash Flow

Operating Cash Flow

$642,000

Free Cash Flow

-$5M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$510M

Total Liabilities

$112M

Stockholders' Equity

$397M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$76M	-35.8%
Gross Profit	$32M	$61M	-47.9%
Operating Income	-$28M	$10M	-368.2%
Net Income	-$34M	$8M	-541.3%

Revenue Segments

Implantable Collamer Lenses

$146M99%

Other Surgical Products

$1M1%